European Union:
European Agency Launches Central Repository To Facilitate Assessment Of Medicines Safety Reports
18 February 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
On January 26, 2015, the European Medicines Agency launched an
electronic repository for periodic safety
update reports ("PSURs") and their assessment reports.
The central platform, created in accordance with the
pharmacovigilance legislation of the EU, will contain all
information related to PSURs in the EU with the aim of facilitating
the assessment of PSURs by medicines regulatory authorities in the
EU.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from European Union
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...